The present invention relates to formula I compounds having antitumoural activities through, as one possible biological target, the molecular chaperone heat shock protein 90 (Hsp90) inhibition. The invention includes the use of such compounds in medicine, in relation to cancer disease as well as other diseases where an inhibition of Hsp90 is responsive, and the pharmaceutical compositions containing such compounds.
本发明涉及具有抗肿瘤活性的I式化合物,其中一种可能的
生物靶点是分子伴侣热休克蛋白90(Hsp90)的抑制作用。本发明包括在医学上使用这些化合物,与癌症疾病以及其他需要抑制Hsp90的疾病有关,并且包括含有这些化合物的制药组合物。